.Merck defeats incomes desires, increases purchases overview on strong demand for top drugs like Keytruda CNBCMerck & Co. (MRK United States) Beats Revenue Forecasts as Keytruda Purchases Rise BloombergMerck Supply: Pharma Titan Posts Tough End Results, However Outlook Tumbles Short Financier's Service DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck trumps earnings and also sales assumptions amid Keytruda advantage, but gives mixed full-year overview MarketWatch.